psalexa
logo

Non Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing (NIPT) Market by Test Type (MaterniT21 PLUS, NIFTY, Harmony, Panorama, PrenaTest, Verifi), by Geography (US, UK, Germany, France, China, India, Japan) - Global Market Size, Share, Development, Growth and Demand Forecast, 2014-2020

Published: November 2015
Report Code: LS10347
Available Format:
Pages: 89

Chapter 1. Research Scope and Methodology

1.1 Market Definition

1.2 Market Scope

1.2.1 Global NIPT market breakdown by test type

1.2.2 Global NIPT market breakdown by geography

1.3 Research Methodology and Sources

Chapter 2. Executive Summary

2.1 Key Findings

2.2 Research Summary

Chapter 3. Market Outlook

3.1 Introduction

3.2 Trends in the Market

3.2.1 Increasing number of collaborations and partnerships

3.3 Opportunities in the Market

3.3.1 Emerging markets offer opportunities for non-invasive prenatal testing manufacturers

3.4 Factors Driving the Market and its Impact on Market Forecast

3.4.1 Increasing average maternal age   

3.4.2 Increasing incidence rate of chromosome syndromes

3.4.3 Increasing demand for early and non-invasive fetal testing procedures

3.4.4 Increasing healthcare expenditure

3.4.5 Impact analysis of drivers on market forecast

3.5 Factors Hindering the Market and its Impact on Market Forecast

3.5.1 Stringent regulatory requirements  

3.5.2 Ethical hurdles

3.5.3 Impact analysis of restraints on market forecast

Chapter 4. Global Non-invasive Prenatal Testing Market Size and Forecast (2014 – 2020)

4.1 Global NIPT Market Breakdown by Test Type

4.2 Global NIPT Market Breakdown by Region

Chapter 5. Global Non-invasive Prenatal Testing Market Breakdown by Test Type

5.1 MaterniT21 PLUS Test Market

5.2 NIFTY Test Market

5.3 Harmony Test Market

5.4 Panorama Test Market

5.5 Verifi Test Market

5.6 PrenaTest Market

Chapter 6. Non-invasive Prenatal Testing Market Breakdown by Geography

6.1 North America NIPT Market

6.1.1 North America NIPT market breakdown by test type

6.1.2 North America NIPT market breakdown by country

6.2 Europe NIPT Market

6.2.1 Europe NIPT market breakdown by test type

6.2.2 Europe NIPT market breakdown by country

6.3 Asia-Pacific NIPT Market     

6.3.1 Asia-Pacific NIPT market breakdown by test type  

6.3.2 Asia-Pacific NIPT market breakdown by country

6.4 Rest of the World (RoW) NIPT Market

6.4.1 RoW NIPT market breakdown by test type

Chapter 7. Competitive Analysis

7.1 Porter’s Five Forces of Competitive Position Analysis

7.1.1 Bargaining power of buyers

7.1.2 Bargaining power of suppliers

7.1.3 Threat of new entrants

7.1.4 Intensity of rivalry

7.1.5 Threat of substitutes

7.2 Competitive Positioning of Major Players

7.2.1 Product differentiation analysis

7.2.2 Geographic presence analysis

7.2.3 Competitive positioning

Chapter 8. Company Profiles and Strategic Developments

8.1 Key Company Profiles

8.1.1 Hoffmann-La Roche Ltd

8.1.1.1 Business overview

8.1.1.2 Product and service offerings

8.1.2 Sequenom Inc.

8.1.2.1 Business overview

8.1.2.2 Product and service offerings

8.1.3 Quest Diagnostics Incorporated

8.1.3.1 Business overview

8.1.3.2 Product and service offerings

8.1.4 Illumina Inc.

8.1.4.1 Business overview

8.1.4.2 Product and service offerings

8.1.5 Laboratory Corporation of America Holdings

8.1.5.1 Business overview

8.1.5.2 Product and service offerings

8.1.6 Berry Genomics Co., Ltd.

8.1.6.1 Business overview

8.1.6.2 Product and service offerings

8.1.7 BGI

8.1.7.1 Business overview

8.1.7.2 Product and service offerings

8.1.8 LifeCodexx AG

8.1.8.1 Business overview

8.1.8.2 Product and service offerings

8.1.9 Natera, Inc.

8.1.9.1 Business overview

8.1.9.2 Product and service offerings

8.2 Strategic Developments in the NIPT Market

8.2.1 Mergers & acquisitions

8.2.2 Collaborations and partnerships

8.2.3 Product approval/ launch

8.2.4 Other developments

Chapter 9. Appendix

9.1 List of Abbreviations

 

LIST OF TABLES

 

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2 GLOBAL NIPT MARKET SNAPSHOT

TABLE 3 MAJOR COLLABORATIONS AND PARTNERSHIPS IN THE NIPT MARKET

TABLE 4 RISK OF DOWN SYNDROME AND CHROMOSOMAL ABNORMALITIES AT LIVE BIRTH

TABLE 5 HEALTHCARE EXPENDITURE AS % OF GDP

TABLE 6 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 7 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 8 GLOBAL NIPT MARKET BREAKDOWN BY TEST TYPE, $M (2015–2020)          

TABLE 9 GLOBAL NIPT MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 10 MATERNIT21 PLUS TEST VALIDATION         

TABLE 11 GLOBAL MATERNIT21 PLUS TEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 12 NIFTY TEST STATISTICS (AS OF 2013)

TABLE 13 GLOBAL NIFTY TEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 14 GLOBAL HARMONY TEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 15 GLOBAL PANORAMA TEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 16 VERIFI TEST PERFORMED IN MOST COMMON CHROMOSOMAL ANEUPLOIDES0

TABLE 17 VERIFI TEST PERFORMED IN MOST COMMON SEX ANEUPLOIDES

TABLE 18 GLOBAL VERIFI TEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 19 GLOBAL PRENATEST MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 20 AVERAGE AGE OF MOTHER AT FIRST BIRTH, IN U.S.

TABLE 21 NORTH AMERICA NIPT MARKET BREAKDOWN BY TEST TYPE, $M (2015 – 2020)

TABLE 22 NORTH AMERICA NIPT MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 23 HEALTHCARE EXPENDITURE AS % OF GDP, OF EUROPEAN COUNTRIES

TABLE 24 EUROPE NIPT MARKET BREAKDOWN BY TEST TYPE, $M (2015 – 2020)

TABLE 25 EUROPE NIPT MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 26 HEALTHCARE EXPENDITURE AS % OF GDP, OF ASIA-PACIFIC COUNTRIES

TABLE 27 ASIA-PACIFIC NIPT MARKET BREAKDOWN BY TEST TYPE, $M (2015 – 2020)

TABLE 28 ASIA-PACIFIC NIPT MARKET BREAKDOWN BY COUNTRY, $M (2015 – 2020)

TABLE 29 ROW NIPT MARKET BREAKDOWN BY TEST TYPE, $M (2015 – 2020)

TABLE 30 COMPARISON OF VARIOUS NON-INVASIVE PRENATAL TESTS

TABLE 31 HOFFMANN-LA ROCHE LTD – KEY FACTS

TABLE 32 SEQUENOM INC. – KEY FACTS

TABLE 33 QUEST DIAGNOSTICS INCORPORATED – KEY FACTS

TABLE 34 ILLUMINA INC. – KEY FACTS

TABLE 35 LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FACTS

TABLE 36 BERRY GENOMICS CO., LTD – KEY FACTS

TABLE 37 BGI– KEY FACTS

TABLE 38 LIFECODEXX AG – KEY FACTS       

TABLE 39 NATERA INC. – KEY FACTS

LIST OF FIGURES

FIG 1 MARKET SCOPE FOR GLOBAL NIPT MARKET

FIG 2 RESEARCH METHODOLOGY FOR GLOBAL NIPT MARKET

FIG 3 TYPES OF CHROMOSOMAL ABNORMALITIES

FIG 4 INDICATIONS OF NIPT

FIG 5 PROCEDURE OF NON-INVASIVE PRENATAL TESTING   

FIG 6 FERTILITY AND MISCARRIAGE RATES DUE TO MATERNAL AGE

FIG 7 TRISOMIES IN HUMAN    

FIG 8 GLOBAL NIPT MARKET SIZE BY TEST TYPE, $M (2014–2020)

FIG 9 GLOBAL NIPT MARKET SHARE, BY TEST TYPE (2014)

FIG 10 GLOBAL NIPT MARKET SIZE BY REGION, $M (2014-2020)

FIG 11 GLOBAL NIPT MARKET SHARE, BY REGION (2014)

FIG 12 GLOBAL MATERNIT21 PLUS TEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 13 GLOBAL NIFTY TEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 14 GLOBAL HARMONY TEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 15 PANORAMA TEST PROCEDURE

FIG 16 GLOBAL PANORAMA TEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 17 GLOBAL VERIFI TEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 18 GLOBAL PRENATEST MARKET SIZE BY REGION, $M (2014-2020)

FIG 19 GLOBAL NIPT MARKET SIZE, BY GEOGRAPHY (2020)

FIG 20 PREVELANCE OF DOWN SYNDROME IN THE U.S.

FIG 21 NORTH AMERICA NIPT MARKET SIZE BY TEST TYPE, $M (2014-2020)

FIG 22 NORTH AMERICA NIPT MARKET SHARE, BY TEST TYPE (2014)

FIG 23 NORTH AMERICA NIPT MARKET SIZE BY COUNTRY, $M (2014-2020)

FIG 24 NORTH AMERICA NIPT MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 25 EUROPE NIPT MARKET SIZE BY TEST TYPE, $M (2014-2020)

FIG 26 EUROPE NIPT MARKET SHARE, BY TEST TYPE (2014) 

FIG 27 EUROPE NIPT MARKET SIZE BY COUNTRY, $M (2014-2020)

FIG 28 EUROPE NIPT MARKET SHARE, BY COUNTRY (2014)

FIG 29 ASIA-PACIFIC NIPT MARKET SIZE BY TEST TYPE, $M (2014-2020)

FIG 30 ASIA-PACIFIC NIPT MARKET SHARE, BY TEST TYPE (2014)

FIG 31 ASIA-PACIFIC NIPT MARKET SIZE BY COUNTRY, $M (2014-2020)

FIG 32 ASIA-PACIFIC NIPT MARKET SHARE, BY COUNTRY (2014 AND 2020)

FIG 33 ROW NIPT MARKET SIZE BY TEST TYPE, $M (2014-2020)

FIG 34 ROW NIPT MARKET SHARE, BY TEST TYPE (2014)

FIG 35 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 36 GLOBAL AVAILABILITY OF NIPT

FIG 37 OMPETITIVE POSITIONING OF MAJOR PLAYERS

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 4500
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 5500
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 8500

Pre-Purchase Enquiry